Article ; Online: Engineered human osteoarthritic cartilage organoids.
2024 Volume 308, Page(s) 122549
Abstract: The availability of human cell-based models capturing molecular processes of cartilage degeneration can facilitate development of disease-modifying therapies for osteoarthritis [1], a currently unmet clinical need. Here, by imposing specific inflammatory ...
Abstract | The availability of human cell-based models capturing molecular processes of cartilage degeneration can facilitate development of disease-modifying therapies for osteoarthritis [1], a currently unmet clinical need. Here, by imposing specific inflammatory challenges upon mesenchymal stromal cells at a defined stage of chondrogenesis, we engineered a human organotypic model which recapitulates main OA pathological traits such as chondrocyte hypertrophy, cartilage matrix mineralization, enhanced catabolism and mechanical stiffening. To exemplify the utility of the model, we exposed the engineered OA cartilage organoids to factors known to attenuate pathological features, including IL-1Ra, and carried out mass spectrometry-based proteomics. We identified that IL-1Ra strongly reduced production of the transcription factor CCAAT/enhancer-binding protein beta [2] and demonstrated that inhibition of the C/EBPβ-activating kinases could revert the degradative processes. Human OA cartilage organoids thus represent a relevant tool towards the discovery of new molecular drivers of cartilage degeneration and the assessment of therapeutics targeting associated pathways. |
---|---|
MeSH term(s) | Humans ; Organoids/metabolism ; Organoids/pathology ; Osteoarthritis/pathology ; Osteoarthritis/metabolism ; Tissue Engineering/methods ; Mesenchymal Stem Cells/metabolism ; Mesenchymal Stem Cells/cytology ; Chondrogenesis ; Chondrocytes/metabolism ; Chondrocytes/pathology ; Cartilage, Articular/pathology ; Cartilage, Articular/metabolism ; Cartilage/pathology ; Cartilage/metabolism ; CCAAT-Enhancer-Binding Protein-beta/metabolism ; Proteomics |
Chemical Substances | CCAAT-Enhancer-Binding Protein-beta |
Language | English |
Publishing date | 2024-03-22 |
Publishing country | Netherlands |
Document type | Journal Article ; Research Support, Non-U.S. Gov't |
ZDB-ID | 603079-8 |
ISSN | 1878-5905 ; 0142-9612 |
ISSN (online) | 1878-5905 |
ISSN | 0142-9612 |
DOI | 10.1016/j.biomaterials.2024.122549 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 2371: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.